Accessibility Menu
 
Bio-Techne logo

Bio-Techne

(NASDAQ) TECH

Current Price$43.30
Market Cap$6.78B
Since IPO (1992)+7,988%
5 Year-56%
1 Year-10%
1 Month-26%

Bio-Techne Financials at a Glance

Market Cap

$6.78B

Revenue (TTM)

$1.21B

Net Income (TTM)

$109.57M

EPS (TTM)

$0.70

P/E Ratio

62.19

Dividend

$0.32

Beta (Volatility)

1.15 (Average)

Price

$43.30

Volume

235,263

Open

$45.01

Previous Close

$43.30

Daily Range

$43.22 - $45.53

52-Week Range

$43.20 - $72.16

TECH: Motley Fool Moneyball Superscore

63

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bio-Techne

Industry

Life Sciences Tools and Services

Employees

3,100

CEO

Kim Kelderman

Headquarters

Minneapolis, MN 55413, US

TECH Financials

Key Financial Metrics (TTM)

Gross Margin

65%

Operating Margin

13%

Net Income Margin

9%

Return on Equity

5%

Return on Capital

6%

Return on Assets

4%

Earnings Yield

1.61%

Dividend Yield

0.74%

Payout Ratio

45.47%

Stock Overview

Market Cap

$6.78B

Shares Outstanding

156.57M

Volume

235.26K

Avg. Volume

2.53M

Financials (TTM)

Gross Profit

$790.27M

Operating Income

$102.25M

EBITDA

$216.88M

Operating Cash Flow

$287.56M

Capital Expenditure

$31.01M

Free Cash Flow

$256.55M

Cash & ST Invst.

$162.19M

Total Debt

$444.06M

Bio-Techne Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$311.42M

-1.5%

Gross Profit

$208.29M

-2.9%

Gross Margin

66.88%

N/A

Market Cap

$6.78B

N/A

Market Cap/Employee

$2.19M

N/A

Employees

3,100

N/A

Net Income

$51.06M

+126.0%

EBITDA

$99.66M

+46.9%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Net Cash

$80.50M

+71.5%

Accounts Receivable

$217.92M

-8.1%

Inventory

$201.18M

+5.3%

Long Term Debt

$276.14M

-32.6%

Short Term Debt

$14.18M

+0.9%

Return on Assets

4.30%

N/A

Return on Invested Capital

6.41%

N/A

Free Cash Flow

$77.58M

+150.3%

Operating Cash Flow

$86.66M

+110.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
QGENQiagen N.V.
$32.98-0.93%
CORTCorcept Therapeutics Incorporated
$56.37-3.31%
CAICaris Life Sciences, Inc.
$14.55-4.59%
BMRNBioMarin Pharmaceutical Inc.
$51.81-2.69%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.95-0.04%
FFord Motor Company
$13.40-0.07%
POETPoet Technologies
$15.97-0.22%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$15.06-0.10%

Questions About TECH

What is the current price of Bio-Techne?

Bio-Techne is trading at $43.30 per share.

What is the 52-week range for Bio-Techne?

Over the past 52 weeks, Bio-Techne has traded between $43.20 and $72.16.

How much debt does Bio-Techne have?

As of the most recent reporting period, Bio-Techne reported total debt of $290.32M.

How much cash does Bio-Techne have on hand?

Bio-Techne reported $209.82M in cash and cash equivalents in its most recent financial results.

What is Bio-Techne’s dividend yield?

Bio-Techne currently has a dividend yield of 0.74%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.